July 30, 2020
Advance Online
Advance Online
FDA Approves Stelara® for Pediatric Psoriasis Patients
Pediatric patients 6 to 11 years of age have a new treatment option.
Pediatric patients 6 to 11 years of age have a new treatment option.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.